Intrapatient variation in PD-L1 expression and tumor mutational burden and the impact on outcomes to immune checkpoint inhibitor therapy in patients with non-small-cell lung cancer

Alessandro Di Federico, Stephanie Alden, James W. Smithy, B. Ricciuti, Joao V. Alessi, Xinan Wang, Federica Pecci, Giuseppe Lamberti, Malini Gandhi, Victor R. Vaz, Liam F. Spurr, Lynette M. Sholl, Kathleen L. Pfaff, Scott J. Rodig, Y Y Li, Andrew D. Cherniack, Mari Nishino, Bruce E. Johnson, Mark M. Awad